How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

In addition to the congressional primary victories of Claire Valdez and Darializa Avila Chevalier — both backed by the New York City chapter of the Democratic Socialists of America — candidates ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

“Motivated by ignorance” and “a hatred of American institutions,” the DSA aims “to dismantle the American criminal-justice system” as an instrument of “class warfare, marvels Barry Latzer at City ...